Predicting SF-6D from the European organization for treatment and research of cancer quality of life questionnaire scores in patients with colorectal cancer

Value in Health

Volumn 16, Issue 2, 2013, Pages 373-384

  Wong, Carlos King Ho ^a   Lam, Cindy L K ^a   Wan, Y F ^a   Rowen, Donna ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

colorectal cancer; EORTC QLQ C30; mapping; preference based scores; quality of life; SF 6D

Indexed keywords

ADULT; AGED; ANOREXIA; ANXIETY; ARTICLE; BODY IMAGE; COLORECTAL CANCER; FEMALE; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RESPONSE VARIABLE; SHORT FORM 6D; VALIDATION STUDY;

AGED; BAYES THEOREM; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; FEMALE; HONG KONG; HUMANS; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PSYCHOMETRICS; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE; STATISTICS, NONPARAMETRIC; SURGICAL STOMAS;

EID: 84874891850     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2012.12.004     Document Type: Article

References (50)

1. Z.F. Gellad, and D. Provenzale Colorectal cancer: national and international perspective on the burden of disease and public health impact Gastroenterology 138 2010 2177 2190
2. J.H. Best, L.P. Garrison, and W. Hollingworth Preference values associated with stage III colon cancer and adjuvant chemotherapy Qual Life Res 19 2010 391 400
3. T. Shiroiwa, T. Fukuda, and K. Tsutani Health utility scores of colorectal cancer based on societal preference in Japan Qual Life Res 18 2009 1095 1103
4. D. Dobrez, D. Cella, and A.S. Pickard Estimation of patient preference-based utility weights from the Functional Assessment of Cancer Therapy-General Value Health 10 2007 266 272
5. J.A. Dominitz, and D. Provenzale Patient preferences and quality of life associated with colorectal cancer screening Am J Gastroenterol 92 1997 2171 2178
6. P. Dolan Modeling valuations for EuroQol health states Med Care 35 1997 1095 1108
7. J. Brazier, J. Roberts, and M. Deverill The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 2002 271 292
8. D. Feeny, W. Furlong, and G.W. Torrance Multiattribute and single-attribute utility functions for the health utilities index Mark 3 system Med Care 40 2002 113 128
9. D. Rowen Brazier J, Young T, et al. Deriving a preference-based measure for cancer using the EORTC QLQ-C30 Value Health 14 2011 721 731
10. National Institute for Clinical Excellence. Guide to the Methods of Technology Appraisal (reference N1618). London: National Institute for Clinical Excellence, 2008.
11. J.E. Brazier, Y. Yang, and A. Tsuchiya A review of studies mapping (or cross walking) non-preference-based measures of health to generic preference-based measures Eur J Health Econ 11 2010 215 225
12. D. Cella, D. Tulsky, and G. Gray The Functional Assessment of Cancer Therapy scale: development and validation of the general measure J Clin Oncol 11 1993 570 579
13. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
14. W.L. Ward, E.A. Hahn, and F. Mo Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument Qual Life Res 8 1999 181 195
15. M.A.G. Sprangers, A. te Velde, and N.K. Aaronson The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life Eur J Cancer 35 1999 238 247
16. C.K.H. Wong, C.L.K. Lam, and W.L. Law Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm J Eval Clin Pract 18 2012 1186 1195
17. C.C. Law, W.W.T. Lam, and Y.T. Fu Validation of the Chinese version of the EORTC colorectal cancer-specific quality-of-life questionnaire module (QLQ-CR38) J Pain Symptom Manage 35 2008 203 213
18. R.N. Whistance, T. Conroy, and W. Chie Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer Eur J Cancer 45 2009 3017 3026
19. M.M. Versteegh, A. Leunis, and J.J. Luime Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D Med Decis Making 32 2012 554 568
20. E.J. Kim, S.K. Ko, and H.Y. Kang Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients Qual Life Res 21 2012 1193 1203
21. M. Versteegh, D.L. Rowen, and J.E. Brazier Mapping onto EQ-5D for patients in poor health Health Qual Life Outcomes 8 2010 141
22. R.W. Jang, P.K. Isogai, and N. Mittmann Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer J Thorac Oncol 5 2010 1953 1957
23. R. Crott, and A. Briggs Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences Eur J Health Econ 11 2010 427 434
24. L. McKenzie, and M. van der Pol Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data Value Health 12 2009 167 171
25. N. Kontodimopoulos, V.H. Aletras, and D. Paliouras Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments Value Health 12 2009 1151 1157
26. P. Wu EQ, and H.F. Max Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients Value Health 10 2007 408 414
27. C.L.K. Lam, J. Brazier, and S.M. McGhee Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population Value Health 11 2008 295 303
28. Lin FJ, Longworth L, Pickard A. Evaluation of content on EQ-5D as compared to disease-specific utility measures. Qual Life Res 2012 June 23 [Epub ahead of print].
29. A.S. Pickard, J.W. Shaw, and H.W. Lin A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Value Health 12 2009 977 988
30. C.K.H. Wong, C.L.K. Lam, and D. Rowen Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to SF-6D in Chinese patients with colorectal neoplasm Value Health 15 2012 495 503
31. C.K.H. Wong, C.L.K. Lam, and J.T.C. Poon Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective J Eval Clin Pract 18 2012 1203 1210
32. Wong CKH, Lam CLK, Law WL, et al. Condition-specific measure was more responsive than generic measure in colorectal cancer: all but social domains. J Clin Epidemiol 2013 [Epub ahead of print].
33. S. Gujral, T. Conroy, and C. Fleissner Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire Eur J Cancer 43 2007 1564 1573
34. P.M. Fayers, N.K. Aaronson, and K. Bjordal The EORTC QLQ - C30 Scoring Manual 3rd ed. 2001 European Organization for Research and Treatment of Cancer Brussels
35. S.M. McGhee, J. Brazier, and Lam CLK Quality-adjusted life years: population-specific measurement of the quality component Hong Kong Med J 17 Suppl 6 2011 S17 S21
36. L.N. Ferreira, P.L. Ferreira, and L.N. Pereira A Portuguese value set for the SF-6D Value Health 13 2010 624 630
37. L.N. Cruz, S.A. Camey, and J.F. Hoffmann Estimating the SF-6D value set for a population-based sample of Brazilians Value Health 14 Suppl 1 2011 S108 S114
38. R. Ara Brazier J. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available) Value Health 11 2008 1131 1143
39. P.W. Sullivan, and V. Ghushchyan Preference-based EQ-5D index scores for chronic conditions in the United States Med Decis Making 26 2006 410 420
40. P. Franks, E.I. Lubetkin, and M.R. Gold Mapping the SF-12 to the EuroQol EQ-5D index in a National US sample Med Decis Making 24 2004 247 254
41. J.E. Brazier, and J. Roberts The estimation of a preference-based measure of health from the SF-12 Med Care 42 2004 851 859
42. J. Brazier, C. Czoski-Murray, and J. Roberts Estimation of a preference-based index from a condition-specific measure: The King's Health Questionnaire Med Decis Making 28 2008 113 126
43. D.L. Rowen, J.E. Brazier, and J. Roberts Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes 7 2009 27
44. Y.B. Cheung, J. Thumboo, and F. Gao Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D utility index Value Health 12 2009 371 376
45. J. Hanmer Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36 Value Health 12 2009 958 966
46. K. Goldsmith, M. Dyer, and M. Buxton Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease Health Qual Life Outcomes 8 2010 54
47. H.J. Starkie, A.H. Briggs, and M.G. Chambers Predicting EQ-5D values using the SGRQ Value Health 14 2011 354 360
48. A.M. Gray, O. Rivero-Arias, and P.M. Clarke Estimating the association between SF-12 responses and EQ-5D utility values by response mapping Med Decis Making 26 2006 18 29
49. Q.A. Le, and J.N. Doctor Probabilistic mapping of descriptive health status responses onto health state utilities using Bayesian networks: an empirical analysis converting SF-12 into EQ-5D utility index in a national US sample Med Care 49 2011 451 460
50. C.K.H. Wong, C.L.K. Lam, and B. Mulhern Measurement invariance of the functional assessment of cancer therapy-colorectal quality-of-life instrument among modes of administration Qual Life Res 2012 Sep 28 [Epub ahead of print]